On Invalid Date, Aileron Therapeutics (NASDAQ: ALRN) reported Q1 2023 earnings per share (EPS) of -$1.05, up 43.55% year over year. Total Aileron Therapeutics earnings for the quarter were -$4.78 million. In the same quarter last year, Aileron Therapeutics's earnings per share (EPS) was -$1.86.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.